• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Lynch Choices Digital Tool Demonstrates High Usability and Feasibility in Survey Study

by
November 13, 2026
in Cancer, Health
Reading Time: 3 mins read
0
Lynch Choices Digital Tool Demonstrates High Usability and Feasibility in Survey Study

Lynch Choices Digital Tool Demonstrates High Usability and Feasibility in Survey Study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A preliminary cross-sectional evaluation has found that a digital decision support intervention known as Lynch Choices demonstrated high proof-of-concept acceptability, usability, and pilot feasibility among individuals living with Lynch syndrome and their relatives. Lynch syndrome is an inherited condition that exposes individuals to elevated lifetime cancer risks, prompting complex decisions regarding clinical management. The intervention incorporates person-based, theory-informed decision aids designed to support informed, values-based choices regarding daily aspirin use and gynaecological risk-reducing surgery.

The study sought to evaluate the acceptability and feasibility of offering Lynch Choices within routine inherited cancer care, specifically examining its performance in an unsupervised, real-world setting. Between January and August 2024, researchers advertised an online survey across the United Kingdom and Ireland using a clinical genetics service, patient advocacy organisations, and social media channels. Eligible participants included adults who self-identified as having Lynch syndrome alongside their family members, providing an opportunity to capture perspectives from both confirmed carriers and those navigating shared familial risks.

Recruitment activities ultimately exceeded the researchers’ prespecified target sample size of 50 participants, suggesting an active willingness among eligible individuals to engage with digital decision support tools outside of formal clinical encounters. In total, 81 participants consented to the evaluation, and 66 individuals, or 81 percent of those consented, submitted sufficient survey data to be included in the primary analysis. The overall response rate could not be quantified because the total reach of the community and social media advertisements remained unquantifiable.

The analysed cohort displayed broad geographic dispersion across the United Kingdom and Ireland, encompassing a wide range of ages. In addition to demographic items, the cross-sectional survey captured self-reported health literacy screening data alongside targeted evaluations of Lynch Choices via Likert-scale items and optional free-text comments.

Baseline assessments revealed that health literacy levels among the surveyed participants were generally high. Within the analysed sample, 85 percent of respondents reported that they never required assistance when reading written materials, while 79 percent expressed extreme confidence when completing forms.

Evaluation scores for the digital tool were consistently favourable across all assessed domains. Specifically, 97 percent of responding participants found Lynch Choices helpful, 96 percent agreed that it was easy to understand, and 96 percent reported that it was easy to use. Furthermore, 91 percent of respondents stated that they would recommend the platform to others, while optional free-text comments contributed positive qualitative feedback alongside constructive suggestions for the platform’s ongoing refinement.

The study authors noted that while early findings support implementation feasibility in unsupervised contexts, continued evaluation remains critical. Future work must assess acceptability and usability among individuals possessing lower digital confidence or lower health literacy to prevent the unintended widening of existing health disparities. Because the present evaluation reflects early proof-of-concept testing, planned refinements will seek to optimise delivery and improve inclusion, reach, and general acceptability across broader populations.

Subsequent research phases are planned to evaluate the direct psychological and clinical effects of Lynch Choices, including its impact on patient knowledge, decisional conflict, psychological well-being, and the actual uptake of cancer prevention options. The researchers also indicated that the core co-design framework underlying the Lynch Choices intervention may eventually be adapted to support individuals facing other inherited cancer predisposition syndromes.

The investigation emerged from a collaborative development process that brought together multidisciplinary expertise and patient stakeholders. Specifically, the intervention was designed with input from the CanGene-CanVar Patient Reference Panel alongside the International Lynch Decision Aid Expert Partner Panel.

The preliminary findings, published in BMC Cancer, demonstrate that offering structured decision support interventions outside formal genetics appointments is practically feasible. Because participants engaged effectively through digital channels, the researchers underscored that the platform’s core person-based architecture could offer a transferable blueprint for developing similar decision aids tailored to other hereditary cancer syndromes.

Subject of Research: Acceptability and usability of the Lynch Choices digital decision support intervention

Article Title: Acceptability, usability and pilot implementation feasibility of the Lynch Choices digital decision support intervention: a preliminary survey evaluation by individuals with Lynch syndrome and their relatives

Article References: Kohut, K., Turner, L., Smith, T., Horgan, R., Foster, R., Hanson, H., Snape, K., Burn, J., Domínguez-Valentin, M., on behalf of the CanGene-CanVar Patient Reference Panel, Dale, C., Duncombe, S., Gold, R., Patton, S., Rook, W., Stephens, R., Turner, L., Vale, F., White, H., … Foster, C. (2026). Acceptability, usability and pilot implementation feasibility of the Lynch Choices digital decision support intervention: a preliminary survey evaluation by individuals with Lynch syndrome and their relatives. BMC Cancer. https://doi.org/10.1186/s12885-026-17300-8

Image Credits: AI Generated

DOI: 10.1186/s12885-026-17300-8

Keywords: Lynch syndrome, digital decision support, decision aids, cancer risk management, inherited cancer care, aspirin chemoprevention, risk-reducing surgery, patient acceptability, usability evaluation, pilot feasibility, health literacy, cross-sectional survey, shared decision-making, clinical genetics, patient engagement, gynaecological surgery

News Source: Nathaniel Bowman. (November 13, 2026). Lynch Choices Digital Tool Demonstrates High Usability and Feasibility in Survey Study. Scienmag.

Tags: aspirin chemopreventioncancer risk managementclinical geneticscross-sectional surveydecision aidsdigital decision supportgynaecological surgeryhealth literacyinherited cancer careLynch syndromepatient acceptabilitypatient engagementpilot feasibilityRisk-Reducing Surgeryshared decision-makingusability evaluation
Share12Tweet7Share2ShareShareShare1

Related Posts

Sequential Companion Diagnostics and Genomic Profiling Escalate Cancer Costs in Japan

Sequential Companion Diagnostics and Genomic Profiling Escalate Cancer Costs in Japan

November 17, 2026
Free Farrowing Shortened Farrowing Duration on One Farm Without Increasing Piglet Mortality

Free Farrowing Shortened Farrowing Duration on One Farm Without Increasing Piglet Mortality

November 17, 2026

Over a Third of Older Wrist Fracture Patients Lack Osteoporosis Treatment

November 17, 2026

Early Screen Exposure Linked to Autism Traits but Causation Remains Unproven

November 17, 2026

POPULAR NEWS

  • Review Links Hyperinsulinaemia to Molecular Pathways in Cholesterol Gallstone Formation

    Review Links Hyperinsulinaemia to Molecular Pathways in Cholesterol Gallstone Formation

    29 shares
    Share 12 Tweet 7
  • Self-Assessed Hirsutism Accurately Flags Endocrine and Metabolic Disruptions in Oligomenorrheic Women

    29 shares
    Share 12 Tweet 7
  • Genomic Radiosensitivity Metrics Fail to Predict Survival in Canine Sinonasal Tumors

    29 shares
    Share 12 Tweet 7
  • Global Review Highlights Escalating Burden and Care Deficits for Migraine Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Sequential Companion Diagnostics and Genomic Profiling Escalate Cancer Costs in Japan

Animal Models Reveal Microenvironment Signals Drive Neurofibromatosis Tumor Growth and Progression

Free Farrowing Shortened Farrowing Duration on One Farm Without Increasing Piglet Mortality

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.